Recommendation of the President regarding #PPZ #48aa – Prevention of chronic HCV and HBV infections
Recommendation No. 79/2025 of September 18, 2025, of the President of the Agency for Health Technology Assessment and Tariff System on recommended medical technologies, activities carried out under health policy programs, and conditions for the implementation of these programs, concerning the prevention of chronic HCV and HBV infections
The recommendation contains a model solution for a given health problem – prevention of chronic HCV and HBV infections
The recommendation exempts local government units from the obligation to submit a health policy program prepared in accordance with its content for review.
Thus, the recommendation serves as a model for local government units preparing draft programs for this health problem.
The President of the Agency recommends that health policy programs for the general population include educational activities related to the prevention of hepatitis C and B infections, as well as the dissemination of information on the possibility of participating in a centrally coordinated program for the detection of anti-HCV antibodies.
Therefore, from September 18, 2025, in order to prepare PPZs for the prevention of chronic HCV and HBV infections, the provisions of Recommendation No. 79/2025 should be taken into account, and then a statement of compliance of the PPZ draft with this recommendation should be sent to the Agency pursuant to Article 48aa(11) of the Act.
There is no need to modify the PPZ currently in force, which entered into force before the publication of Recommendation 79/2025. It is not possible to continue future editions of the PPZ in an unchanged form.